Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 10, 2003, Pages 565-568

  Anderson, T M ^a   Hess, S D ^a   Egilmez, N K ^a   Nwogu, C E ^a   Lenox, J M ^a   Bankert, R B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cell culture; Disease outcome; NSCLC; Relapse; SCID mice

Indexed keywords

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL CULTURE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARGE CELL CARCINOMA; LEUKEMIA CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SCID MOUSE; TISSUE DIFFERENTIATION; TUMOR BIOPSY; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; MALE; MEDICAL RECORDS; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0242266386     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0473-3     Document Type: Article

References (14)

1. American Cancer Society (2001) 2000 Cancer facts and figures: selected cancers, vol 2000. American Cancer Society, Atlanta
2. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 11:1710-1717
3. Mountain CF, Dresler CM (1997) Regional lymph node classification for lung cancer staging. Chest 11:1718-1723
4. Saunders CAB, Dussek JE, O'Doherty MJ, Maisey MN (1999) Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer. Ann Thorac Surg 67:790-797
5. Beckett WS (1993) Epidemiology and etiology of lung cancer. Clin Chest Med 14:1
6. Yamada M, Shiroko T, Kawaguchi Y, Sugiyama Y, Egilmez NK, Chen FA, Bankert RB (2001) CD4-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors. Int J Cancer 92:589-599
7. Cox DR (1972) Regression models and life-tables. J R Stat Soc B 34:187-220
8. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-486
9. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop GM, Freedman MH, Phillips RA, Dick JE (1989) A model of human acute lymphoblastic leukemia in immune deficient SCID mice. Science 246:1597
10. Kamel-Reid S, Letarte M, Doedens M, et al. (1991) Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in SCID mice. Blood 78:2973-2981
11. Uckun FM, Sather H, Reaman G, et al. (1995) Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 85:873-878
12. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass M, Taub DT, Iannettoni MD, Whyte RI, Strieter RM (1996) Interferon-γ inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 184:981
13. Hess SD, Egilmez NK, Bailey N, Anderson TM, Mathiowitz E, Bernstein SH, Bankert RB (2003) Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-γ. J Immunol 170:400-412
14. Bankert RB, Egilmez NK, Hess SD (2001) Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol 22:386-393